New injection aims to boost platelets when standard treatments fail
NCT ID NCT06534255
Summary
This early-stage study is testing an experimental injection called MegaLT for people with dangerously low platelet counts that haven't improved after cancer treatments like radiation, chemotherapy, or transplants. The trial will check if the treatment is safe, how the body processes it, and whether it helps increase platelet levels. It involves 10 participants at a single hospital in China.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for REFRACTORY THROMBOCYTOPENIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
The First Affiliated Hospital of University of Science and Technology of China (Anhui Provincial Hospital)
Hefei, Anhui, 230036, China
Conditions
Explore the condition pages connected to this study.